{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:42:47Z","timestamp":1793965367271,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.leukres.2024.107452","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T12:59:34Z","timestamp":1707224374000},"page":"107452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement"],"prefix":"10.1016","volume":"137","author":[{"given":"Hannah","family":"Goulart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahniel","family":"Sastow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Moshier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"29","key":"10.1016\/j.leukres.2024.107452_bib1","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2024.107452_bib2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3109\/10428194.2014.953148","article-title":"Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia","volume":"56","author":"Rozovski","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.leukres.2024.107452_bib3","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3906\/sag-2103-127","article-title":"Central nervous system involvement in patients with acute myeloid leukemia","volume":"51","author":"Yasar","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.leukres.2024.107452_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12885-015-1376-9","article-title":"Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults","volume":"15","author":"Cheng","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.leukres.2024.107452_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbmt.2014.11.683","article-title":"Central nervous system involvement in acute myeloid leukemia patients undergoing hematopoietic cell transplantation","volume":"21","author":"Bar","year":"2015","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"4","key":"10.1016\/j.leukres.2024.107452_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.seminhematol.2018.02.006","article-title":"Involvement of central nervous system in adult patients with acute myeloid leukemia: incidence and impact on outcome","volume":"55","author":"Del Principe","year":"2018","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.leukres.2024.107452_bib7","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.leukres.2024.107452_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.leukres.2024.107452_bib9","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.leukres.2024.107452_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijrobp.2010.01.062","article-title":"Impact of cranial irradiation added to intrathecal conditioning in hematopoietic cell transplantation in adult acute myeloid leukemia with central nervous system involvement","volume":"80","author":"Mayadev","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.leukres.2024.107452_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/CMAR.S125259","article-title":"Symptomatic central nervous system involvement in adult patients with acute myeloid leukemia","volume":"9","author":"Alakel","year":"2017","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.leukres.2024.107452_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s12185-016-2063-6","article-title":"Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia","volume":"104","author":"Kwon","year":"2016","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2024.107452_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12253-016-0162-6","article-title":"Central nervous system involvement at the time of allogeneic hematopoietic stem cell transplantation is associated with a poor outcome in patients with acute myeloid leukemia","volume":"23","author":"Ikegawa","year":"2017","journal-title":"Pathol. Oncol. Res."},{"issue":"5","key":"10.1016\/j.leukres.2024.107452_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/ejh.13314","article-title":"Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment","volume":"103","author":"Prem","year":"2019","journal-title":"Eur. J. Haematol."},{"issue":"12","key":"10.1016\/j.leukres.2024.107452_bib15","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.bbmt.2014.09.001","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with central nervous system involvement","volume":"20","author":"Aoki","year":"2014","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.leukres.2024.107452_bib16","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1182\/blood-2019-125361","article-title":"Acute myeloid leukemia with high risk features: routine central nervous system evaluation may be beneficial","volume":"134","author":"Yogarajah","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.leukres.2024.107452_bib17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2024.107452_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1179\/1607845413Y.0000000117","article-title":"Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia","volume":"19","author":"Zheng","year":"2014","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.leukres.2024.107452_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1988.6.3.495","article-title":"High peripheral blast count in adult acute myelogenous leukemia is a primary risk factor for CNS leukemia","volume":"6","author":"Cassileth","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2024.107452_bib20","unstructured":"Network NCC. Acute Myeloid Leukemia Version 3.2023 April 5, 20232023 [Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf."},{"issue":"22","key":"10.1016\/j.leukres.2024.107452_bib21","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1182\/bloodadvances.2021004999","article-title":"CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials","volume":"5","author":"Ganzel","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2024.107452_bib22","first-page":"1","article-title":"Exclusion of acute myeloid leukemia patients with central nervous system involvement from clinical trials: an analysis of the national institutes of health clinical trials registry from 2012-2022","author":"Sastow","year":"2023","journal-title":"Acta Haematol."},{"key":"10.1016\/j.leukres.2024.107452_bib23","first-page":"1","article-title":"Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement","author":"Sastow","year":"2023","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2024.107452_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J. Hematol. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:04:37Z","timestamp":1758935077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":24,"alternative-id":["S0145212624000183"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107452","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107452"}}